|
Wednesday, 14 October 2009 |
|
Small and medium pharmaceutical companies are in a state of crisis. Their new set of problems started with the implementation of Good Manufacturing Practices as per the amended norms of Schedule M of the Drugs & Cosmetics Act in 2005. |
|
Read more...
|
|
|
<< Start < Prev 1 2 Next > End >>
|
| Results 1 - 8 of 15 |